LMIM
EVH icon

Lockheed Martin Investment Management’s Evolent Health EVH Stock Holding History

Lockheed Martin Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,650
Closed -$510K – 132
2017
Q3 		$510K Hold
28,650
– – 0.03% 127
2017
Q2 		$726K Sell
28,650
-26,350
-48% -$634K 0.04% 119
2017
Q1 		$1.23M Buy
+55,000
New +$1.06M 0.07% 105

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

Lockheed Martin Investment Management's EVH Position: Q4 2017 in Review

Lockheed Martin Investment Management sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 28,650 shares — an estimated $510K sold.

Lockheed Martin Investment Management first reported a position in EVH in Q1 2017 and held it in 3 quarters. The position peaked at $1.23M in Q1 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • Lockheed Martin Investment Management reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 28,650 Evolent Health shares in Q4 2017, an estimated $510K.
  • Lockheed Martin Investment Management first reported a position in Evolent Health in Q1 2017 and held it in 3 quarters.
  • Lockheed Martin Investment Management's Evolent Health position peaked at $1.23M in Q1 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.